Patients with multiple sclerosis (MS) who have recovered from COVID-19 and received a B-cell depleting therapy (ocrelizumab) for at least 1 year were observed to still have T-cell responses. ajmc.com/view/t-cell-respon...
Patients with MS who have recovered from... - My MSAA Community
Patients with MS who have recovered from COVID-19 and a B-cell depleting med observed to still have T-cell responses.
Written by
JMWCO
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
That would be me, thanks for the good news 👍
carolek572CommunityAmbassador
Hurrah, JMWCO That’s fantastic news! I am praying that my T-cells respond when I do ever get COVID-19! 
Yay
Not what you're looking for?
You may also like...
Happy New Year!
It was a little late, but a couple of days ago, it hit me: January 1st was the 5th anniversary...
3 New COVID-19 Treatments Now Available to MS Patients in UK
https://multiplesclerosisnewstoday.com/news-posts/2021/12/22/ms-patients-uk-now-eligible-3-new-covid
Ocrevus - Tomorrow's the Day
Well, tomorrow morning (Thursday) I go in for my first infusion of Ocrevus. I am very nervous, but...
Autologous Stem Cell Transplantation for MS
Autologous Stem Cell Transplantation for MS: Progression-Free Survival Seen in Nearly Half of...
Ocrevus: FDA Approves First Drug to Treat Two Forms of MS
Here is an excerpt from MSAA's article on the latest MS treatment news:
"On March 28, 2017, the...
Side effects of Covid-19 vaccine to people with MS 
Let's Do a Trial Run of Questions for the "Ask the Expert" .
Updated Covid-19 Vaccine
Covid-19 vaccine & MS
